Huizenga Theodore Alan 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Sep 19, 2025
Insider Transaction Report
Form 4
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-09-18$29.17/sh−64$1,867→ 50,242 total
Footnotes (2)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.